التفاصيل البيبلوغرافية
| العنوان: |
Prophylactic oral bisphosphonate therapy in duchenne muscular dystrophy. |
| المؤلفون: |
Srinivasan, Ramesh, Rawlings, David, Wood, Claire L., Cheetham, Tim, Moreno, Aura Cecilia Jimenez, Mayhew, Anna, Eagle, Michelle, Guglieri, Michela, Straub, Volker, Owen, Catherine, Bushby, Kate, Sarkozy, Anna |
| المصدر: |
Muscle & Nerve; Jul2016, Vol. 54 Issue 1, p79-85, 7p |
| مستخلص: |
Introduction: We assessed prophylactic use of bisphosphonate (BP) in Duchenne muscular dystrophy (DMD) patients on glucocorticoid (GC) therapy.Methods: Fifty-two DMD patients on daily GC were offered BP (oral risedronate). Patients were reviewed for tolerability, side effects, bone pain, and fracture frequency. Bone mineral density (BMD) was determined by annual dual energy X-ray absorptiometry. BP-treated patients were compared with 15 BP-naïve patients (untreated cohort).Results: Side effects occurred in 9 patients. Thirty-six patients continued BP therapy for over 12 months (mean, 3.6 years). Five treated patients reported bone pain. Three treated patients suffered a vertebral fracture, significantly less than in the untreated cohort (5/15). Lumbar spine adjusted BMD Z-scores remained unchanged in treated patients and were significantly greater than in the untreated cohort.Conclusions: Prophylactic oral risedronate therapy was tolerated by most DMD patients. It appears to maintain BMD and may reduce fracture rate in DMD patients on GC. Muscle Nerve 54: 79-85, 2016. [ABSTRACT FROM AUTHOR] |
|
Copyright of Muscle & Nerve is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
